GL1X · GenesisL1 explorer

MolNFT v1 · #142386 · protein

Crystal structure of quadruple mutant (N51I+C59R+S108N+I164L) plasmodium falciparum DHFR-ts complexed with BT2, NADPH, and dump

6A2N · Bifunctional dihydrofolate reductase-thymidylate synthase: “Crystal structure of quadruple mutant (N51I+C59R+S108N+I164L) plasmodium falciparum DHFR-ts complexed with…”. X-ray diffraction, 3 ligands (9QR, NAP, UMP), 14 pockets (best…

PDB
6A2N
Type
protein
Length
1,094 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Bifunctional dihydrofolate reductase-thymidylate synthase
UniProt
D9N170
Ligands
9QR, NAP, UMP
Pockets
14 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 31% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BBifunctional dihydrofolate reductase-thymidylate synthaseprotein54731% helix, 24% strandD9N170

Ligands and binding sites

  • 9QR · 5-(4-{3-[(2,4-diamino-6-ethylpyrimidin-5-yl) oxy]propoxy}phenyl)-6-ethylpyrimidine-2,4-diamine · ligand · 2 copies · chains A, B
  • NAP · Nadp nicotinamide-adenine-dinucleotide phosphate · ligand · 2 copies · chains A, B
  • UMP · 2'-deoxyuridine 5'-monophosphate · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

14 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14880.730.82479QR, NAP
26420.720.7963UMP
35130.720.81489QR, NAP
45210.670.7851UMP
53050.560.7635empty

Interfaces

1 interface between chains.

  • A–B · 4184 Ų buried · 51 hydrogen bonds · protein-protein

Compared structures

  • 6A2N · Crystal structure of quadruple mutant (N51I+C59R+S108N+I164L) Plasmodium falciparum… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.